Human Thrombin-Antithrombin Complex (TAT) AssayMax ELISA KitHuman Thrombin-Antithrombin Complex (TAT) AssayMax ELISA Kit
Move your mouse over image or click to enlarge

Human Thrombin-Antithrombin Complex (TAT) AssayMax ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

Cat# Size Price Qty Buy
ET1020-1 96 Well Plate £276.25

Additional Information

Property Value or Rating
Manufacturer Assaypro, LLC.
Product Type AssayMax™ ELISA Kits
Samples Serum, Milk, Cell Culture
Species Human
Reactivity Human
Assay Format Sandwich ELISA
Product Size 96 Well Plate
Range 1.481-120 ng/ml
Plex Number 1
Storage Refer to component labels for details
Entrez Gene 2147; 462
Omim 176930, 107300
UniProt P00734, P01008
UniGene Hs.655207, Hs.75599
Special Notes For Research Use Only, Not To Be Used For Diagnostic Purposes
References * Guven S et al. (2009) The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome. Hypertens Pregnancy. 2011;30(3):275-286 
* Oral B. et al. (2009) Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol 25:110-116 
* Alhumaidan H et al. (2010) Stability of coagulation factors in plasma prepared after a 24-hour room temperature hold. Transfusion 50:1934-1942 
* Godiska LM (2010) THE ROLES OF PLASMA PROTEINS AND NEUTROPHILS IN MELANOMA METASTASIS (TAT kit). 
* Li F et al. (2010) Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. J Thromb Haemost. 8(10):2122-2132 
* Turker Y et al. (2010) Association of Thrombotic and Fibrinolytic Factors with Severity of Culprit Lesion in Patients with Acute Coronary Syndromes Without ST Elevation. Southern Medical Journal 103:289-294 
* Milleret V et al. (2011) ALKALI TREATMENT OF MICROROUGH TITANIUM SURFACES AFFECTS MACROPHAGE/MONOCYTE ADHESION, PLATELET ACTIVATION AND ARCHITECTURE OF BLOOD CLOT FORMATION. European Cells and Materials 21:430-444 
* Molins B et al. (2011) Monomeric CRP is prothrombotic and dissociates from circulating pentameric CRP on adhered activated platelets under flow. Cardiovasc Res doi: 10.1093/cvr/cvr226 
* Peng PH et al. (2011) Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J Proteomics. 74(5):744-57 
* Davies R (2012) The short term effects of endovascular a neurysm repair (ever) on coagulation and cardiovascular morbidity and mortality in patients with infra-renal abdominal aortic aneurysms 
* Miyawaki Y et al. (2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med. 366(25):2390-2396 
* Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 
* Fernandez-Bello I et al. (2013) Behcets disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis. 8:81 
* Momot AP et al. (2014) Allowable values of different parameters of hemostatic system in physiological pregnancy. Kazakhstan Association of Medical Laboratory Diagnostics 4(11):49-59 
* Schilder L et al. (2015) Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities. Blood Purif. 39:297-305 (ET1020-1 TAT and EP1100-1 PAI-1 kits). 
* Lam FW et al. (2016) Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica. 101(7):e277-9 

" title="

* Guven S et al. (2009) The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome. Hypertens Pregnancy. 2011;30(3):275-286 
* Oral B. et al. (2009) Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol 25:110-116 
* Alhumaidan H et al. (2010) Stability of coagulation factors in plasma prepared after a 24-hour room temperature hold. Transfusion 50:1934-1942 
* Godiska LM (2010) THE ROLES OF PLASMA PROTEINS AND NEUTROPHILS IN MELANOMA METASTASIS (TAT kit). 
* Li F et al. (2010) Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. J Thromb Haemost. 8(10):2122-2132 
* Turker Y et al. (2010) Association of Thrombotic and Fibrinolytic Factors with Severity of Culprit Lesion in Patients with Acute Coronary Syndromes Without ST Elevation. Southern Medical Journal 103:289-294 
* Milleret V et al. (2011) ALKALI TREATMENT OF MICROROUGH TITANIUM SURFACES AFFECTS MACROPHAGE/MONOCYTE ADHESION, PLATELET ACTIVATION AND ARCHITECTURE OF BLOOD CLOT FORMATION. European Cells and Materials 21:430-444 
* Molins B et al. (2011) Monomeric CRP is prothrombotic and dissociates from circulating pentameric CRP on adhered activated platelets under flow. Cardiovasc Res doi: 10.1093/cvr/cvr226 
* Peng PH et al. (2011) Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J Proteomics. 74(5):744-57 
* Davies R (2012) The short term effects of endovascular a neurysm repair (ever) on coagulation and cardiovascular morbidity and mortality in patients with infra-renal abdominal aortic aneurysms 
* Miyawaki Y et al. (2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med. 366(25):2390-2396 
* Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 
* Fernandez-Bello I et al. (2013) Behcets disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis. 8:81 
* Momot AP et al. (2014) Allowable values of different parameters of hemostatic system in physiological pregnancy. Kazakhstan Association of Medical Laboratory Diagnostics 4(11):49-59 
* Schilder L et al. (2015) Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities. Blood Purif. 39:297-305 (ET1020-1 TAT and EP1100-1 PAI-1 kits). 
* Lam FW et al. (2016) Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica. 101(7):e277-9 

" target="_blank">

* Guven S et al. (2009) The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome. Hypertens Pregnancy. 2011;30(3):275-286 
* Oral B. et al. (2009) Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome. Gynecol Endocrinol 25:110-116 
* Alhumaidan H et al. (2010) Stability of coagulation factors in plasma prepared after a 24-hour room temperature hold. Transfusion 50:1934-1942 
* Godiska LM (2010) THE ROLES OF PLASMA PROTEINS AND NEUTROPHILS IN MELANOMA METASTASIS (TAT kit). 
* Li F et al. (2010) Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. J Thromb Haemost. 8(10):2122-2132 
* Turker Y et al. (2010) Association of Thrombotic and Fibrinolytic Factors with Severity of Culprit Lesion in Patients with Acute Coronary Syndromes Without ST Elevation. Southern Medical Journal 103:289-294 
* Milleret V et al. (2011) ALKALI TREATMENT OF MICROROUGH TITANIUM SURFACES AFFECTS MACROPHAGE/MONOCYTE ADHESION, PLATELET ACTIVATION AND ARCHITECTURE OF BLOOD CLOT FORMATION. European Cells and Materials 21:430-444 
* Molins B et al. (2011) Monomeric CRP is prothrombotic and dissociates from circulating pentameric CRP on adhered activated platelets under flow. Cardiovasc Res doi: 10.1093/cvr/cvr226 
* Peng PH et al. (2011) Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J Proteomics. 74(5):744-57 
* Davies R (2012) The short term effects of endovascular a neurysm repair (ever) on coagulation and cardiovascular morbidity and mortality in patients with infra-renal abdominal aortic aneurysms 
* Miyawaki Y et al. (2012) Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med. 366(25):2390-2396 
* Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 
* Fernandez-Bello I et al. (2013) Behcets disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity. Orphanet J Rare Dis. 8:81 
* Momot AP et al. (2014) Allowable values of different parameters of hemostatic system in physiological pregnancy. Kazakhstan Association of Medical Laboratory Diagnostics 4(11):49-59 
* Schilder L et al. (2015) Coagulation, fibrinolysis and inhibitors in failing filters during continuous venovenous haemofiltration in critically ill patients with acute kidney injury: effect of anticoagulation modalities. Blood Purif. 39:297-305 (ET1020-1 TAT and EP1100-1 PAI-1 kits). 
* Lam FW et al. (2016) Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica. 101(7):e277-9 

Related Documents